Humanity Forward Urges Action on Bipartisan Insulin Bill
WASHINGTON, June 23, 2022 /PRNewswire/ -- Today, Humanity Forward applauds Senators Susan Collins (R-ME), and Jeanne Shaheen (D-NH) for coming to a bipartisan deal to reduce the skyrocketing price of Insulin for American families and is urging Congress to support and pass the bill into law.
The bill would cap the cost of insulin to $35 per month, which would be a major relief to millions of Americans who depend on the life-saving drug.
"As prices rise for American families, it's increasingly important that we make sure life-saving drugs are within reach," said Paolo Mastgrangelo, Humanity Forward's Head of Government and Policy. "We welcome the efforts by these senators to reach across the aisle and do this on a bipartisan basis, to ensure an immediate and long-lasting fix."
Congress continues to debate the issue of drug prices in bipartisan conversations and in Reconciliation talks as well. Humanity Forward stands ready to work with members in both parties to reduce costs and regulatory burdens on American families.
Humanity Forward is a 501(c)(4) nonprofit organization dedicated to building bipartisan coalitions to advance the economic interests of the American people through federal policy. Uniquely positioned as America's fastest growing, altruistic advocacy organization, our mission is to advance evidence-based policies designed to strengthen families, generate economic growth, and end poverty.
The eighth Aurora Prize for Awakening Humanity was awarded Thursday evening to Dr. Denis Mukwege, a world-renown gynecological surgeon and human rights activist from the Democratic Republic of the Congo (DRC). Dr. Mukwege is the president of Panzi...
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK's National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to...
Charging an electric vehicle (EV) at home is certainly more convenient than using a public charging station, but what are the other benefits? Along with convenience, the...
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...